According to ImmunoPrecise Antibodies's latest financial reports the company's current earnings are A$17.57 Million. In 2023 the company made an earning of -A$19.17 Million, an increase over its 2022 earnings that were of -A$32.9 Million. The earnings displayed on this page is the company's Pretax Income.